This post was originally published on this site
According to the International Data Corporation (IDC), worldwide spending on big data and business analytics (BDA) solutions are expected to reach $215.7 billion this year, an increase of 10.1% over 2020. Also, the global data analytics market is expected to reach $24.63 billion by 2030, exhibiting a CAGR of 25% from 2021.
As such, we believe data analytics stock Cloudera, Inc. (CLDR) is well-positioned to cash in on the industry’s strong growth potential. However, fundamentally weak stock in this space, Celldex (NASDAQ:CLDX) Therapeutics, Inc. (CLDX) might struggle to stay afloat.
